Photo of Steven Chen from Sylvester Comprehensive Cancer Center/LinkedIn
Aug 3, 2024, 10:49
10-gene biomarker that could predict whether colon cancer patients will benefit from adjuvant chemotherapy – Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn:
“We are proud to share that Sylvester’s Dr. Steven Chen has led a study published in Cell Press. This study identifies and validates a 10-gene biomarker that could predict whether colon cancer patients will benefit from adjuvant chemotherapy.
This finding sets the stage for more personalized treatment decisions in the future. Learn how Dr. Chen and his team are advancing precision oncology.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 23, 2025, 05:49
Mar 22, 2025, 16:27
Mar 22, 2025, 14:55
Mar 22, 2025, 14:41
Mar 22, 2025, 14:28
Mar 22, 2025, 13:46
Mar 22, 2025, 13:29
Mar 22, 2025, 13:16